Log in to your Inderes Free account to see all free content on this page.
Arcoma
8.00 SEK
0.00 %
Less than 1K followers
ARCOMA
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Arcoma
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 133.7 | 117.4 | 117.1 | 125.1 | 163.0 | 156.8 | 130.8 |
| growth-% | -12.2 % | -0.2 % | 6.8 % | 30.4 % | -3.8 % | -16.6 % | |
| EBITDA | 13.1 | 6.9 | -2.7 | 9.7 | 12.8 | 21.6 | 13.6 |
| EBIT | 9.1 | 3.6 | -8.8 | 3.1 | 4.7 | 13.7 | 6.2 |
| Profit before taxes | 8.9 | 1.8 | -8.9 | 2.1 | 3.1 | 13.8 | 6.3 |
| Net income | 6.3 | 1.4 | -7.5 | 1.9 | 2.6 | 11.2 | 5.0 |
| EPS | 0.50 | 0.11 | -0.57 | 0.14 | 0.19 | 0.85 | 0.35 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | 0.0 % | 0.0 % | -0.0 % | 0.0 % | 0.0 % | 0.0 % |
Login required
This content is only available for logged in users
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | 9.8 % | 5.9 % | -2.3 % | 7.8 % | 7.8 % | 13.8 % | 10.4 % |
| EBIT-% | 6.8 % | 3.1 % | -7.5 % | 2.5 % | 2.9 % | 8.7 % | 4.8 % |
| ROE | 14.1 % | 2.9 % | -17.0 % | 4.1 % | 5.3 % | 18.8 % | 6.7 % |
| ROI | 7.6 % | 1.5 % | -9.4 % | 1.9 % | 3.1 % | 13.9 % | 5.2 % |
Login required
This content is only available for logged in users